we have provided the first clinical evidence that bortezomib may enhance the activity of chemotherapy in the ABC subtype,” comment the researchers. The molecular classification of DLBCL by gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback